Ono Pharmaceutical has been granted a patent for a drug containing a compound with ABHD6 inhibitory activity for preventing or treating diseases associated with ABHD6. The compound of formula (I-A) or its salt is effective in targeting ABHD6, making it a valuable pharmaceutical ingredient. GlobalData’s report on Ono Pharmaceutical gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Ono Pharmaceutical, Peptide pharmacophores was a key innovation area identified from patents. Ono Pharmaceutical's grant share as of May 2024 was 45%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11981682B2) discloses a compound represented by a specific chemical formula. The compound, described in claim 1, is [(3aS,4R,6aR)-4-[(6-bromo-3-pyridazinyl)amino]hexahydrocyclopenta[c]pyrrol-2(1H)-yl](5-methyl-2-thienyl)methanone. This compound is intended for use in pharmaceutical compositions as an active ingredient.
Furthermore, the patent claims cover pharmaceutical compositions that include the compound mentioned in claim 1 or a pharmaceutically acceptable salt thereof. These compositions are formulated with a pharmaceutically acceptable carrier. Additionally, claim 4 specifies a pharmaceutical composition containing the compound described in claim 2 as the active ingredient, along with a suitable carrier. These compositions are designed for potential therapeutic applications based on the properties of the disclosed compound.
To know more about GlobalData’s detailed insights on Ono Pharmaceutical, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
